University of Miami - Sylvester Comprehensive Cancer Center,3850 Hollywood Blvd — Hollywood, Florida

University of Miami - Sylvester Comprehensive Cancer Center,3850 Hollywood Blvd is a clinical research site located in Hollywood, Florida, United States 33021.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

University of Miami - Sylvester Comprehensive Cancer Center,3850 Hollywood Blvd has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Triple Negative Breast Cancer, PD-L1 Positive.

Sponsors: Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Miami - Sylvester Comprehensive Cancer Center,3850 Hollywood Blvd?

University of Miami - Sylvester Comprehensive Cancer Center,3850 Hollywood Blvd has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Miami - Sylvester Comprehensive Cancer Center,3850 Hollywood Blvd conducted?

University of Miami - Sylvester Comprehensive Cancer Center,3850 Hollywood Blvd has 1 clinical trials on record, with 1 currently active. Their work covers Triple Negative Breast Cancer, PD-L1 Positive.

Is University of Miami - Sylvester Comprehensive Cancer Center,3850 Hollywood Blvd accredited by Crixeo Health?

University of Miami - Sylvester Comprehensive Cancer Center,3850 Hollywood Blvd has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Miami - Sylvester Comprehensive Cancer Center,3850 Hollywood Blvd?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.